Taxes on Earnings (Tables)
|
12 Months Ended |
Oct. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Domestic and Foreign Components of Earnings |
The domestic and foreign components of earnings before taxes were as follows: | | | | | | | | | | | | | | | | | | | | For the fiscal years ended October 31 | | h | 2025 | | 2024 | | 2023 | | | In millions | | U.S. | $ | 107 | | | $ | 537 | | | $ | 650 | | | Non-U.S. | 2,561 | | | 2,742 | | | 2,287 | | | | $ | 2,668 | | | $ | 3,279 | | | $ | 2,937 | |
|
| Schedule of (Benefit from) Provision for Taxes on Earnings |
The provision for (benefit from) taxes on earnings was as follows: | | | | | | | | | | | | | | | | | | | For the fiscal years ended October 31 | | | 2025 | | 2024 | | 2023 | | | In millions | | U.S. federal taxes: | | | | | | | Current | $ | (188) | | | $ | 245 | | | $ | 226 | | | Deferred | (121) | | | 34 | | | (549) | | | Non-U.S. taxes: | | | | | | | Current | 328 | | | 357 | | | 337 | | | Deferred | 95 | | | (193) | | | (305) | | | State taxes: | | | | | | | Current | (13) | | | 33 | | | 42 | | | Deferred | 38 | | | 28 | | | (77) | | | | $ | 139 | | | $ | 504 | | | $ | (326) | |
|
| Schedule of Differences Between U.S. Federal Statutory Income Tax Rate and HP's Effective Tax Rate |
The differences between the U.S. federal statutory income tax rate and HP’s effective tax rate were as follows: | | | | | | | | | | | | | | | | | | | | For the fiscal years ended October 31 | | | 2025 | | 2024 | | 2023 | | U.S. federal statutory income tax rate from continuing operations | 21.0 | % | | 21.0 | % | | 21.0 | % | | State income taxes, net of federal tax benefit | 2.4 | % | | 2.2 | % | | 1.7 | % | | Impact of foreign earnings including GILTI and FDII, net | (2.9) | % | | (1.0) | % | | (1.1) | % | | Research and development (“R&D”) credit | (2.3) | % | | (1.1) | % | | (1.0) | % | | Valuation allowances | (2.5) | % | | (7.1) | % | | (7.3) | % | | Uncertain tax positions and audit settlements | (10.2) | % | | 1.0 | % | | 2.4 | % | Changes in tax laws or rates enacted | 1.4 | % | | 0.3 | % | | (0.3) | % | | Impact of internal reorganization | — | % | | — | % | | (27.4) | % | | Other, net | (1.7) | % | | 0.1 | % | | 0.9 | % | | | 5.2 | % | | 15.4 | % | | (11.1) | % |
|
| Schedule of Reconciliation of Unrecognized Tax Benefits |
A reconciliation of unrecognized tax benefits is as follows: | | | | | | | | | | | | | | | | | | | | For the fiscal years ended October 31 | | | 2025 | | 2024 | | 2023 | | | In millions | | Balance at beginning of year | $ | 1,217 | | | $ | 1,137 | | | $ | 1,045 | | | Increases: | | | | | | | For current year’s tax positions | 85 | | | 82 | | | 61 | | | For prior years’ tax positions | 14 | | | 52 | | | 186 | | | Decreases: | | | | | | | For prior years’ tax positions | (79) | | | (9) | | | (35) | | | Statute of limitations expirations | (338) | | | (33) | | | (8) | | | Settlements with taxing authorities | (34) | | | (12) | | | (112) | | | Balance at end of year | $ | 865 | | | $ | 1,217 | | | $ | 1,137 | |
|
| Schedule of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities |
The significant components of deferred tax assets and deferred tax liabilities were as follows: | | | | | | | | | | | | | | As of October 31 | | | 2025 | | 2024 | | | In millions | | Deferred tax assets: | | | | | Loss and credit carryforwards | $ | 6,792 | | | $ | 7,050 | | | Intercompany transactions—excluding inventory | 208 | | | 357 | | | Fixed assets | 107 | | | 113 | | | Warranty | 81 | | | 100 | | | Employee and retiree benefits | 226 | | | 242 | | | Deferred revenue | 244 | | | 240 | | | Capitalized research and development | 1,187 | | | 1,014 | | | | | | | Operating lease liabilities | 244 | | | 272 | | | Investment in partnership | 672 | | | 710 | | | | | | | Other | 393 | | | 395 | | | Gross deferred tax assets | 10,154 | | | 10,493 | | | Valuation allowances | (6,479) | | | (6,688) | | | Total deferred tax assets | 3,675 | | | 3,805 | | | | | | | Deferred tax liabilities: | | | | | Unremitted earnings of foreign subsidiaries | (36) | | | (107) | | | Right-of-use assets from operating leases | (211) | | | (235) | | | Intangible assets | (121) | | | (159) | | | Cash flow hedges | (5) | | | (24) | | | | | | | Total deferred tax liabilities | (373) | | | (525) | | | Net deferred tax assets | $ | 3,302 | | | $ | 3,280 | |
Deferred tax assets and liabilities included in the Consolidated Balance Sheets as follows: | | | | | | | | | | | | | | As of October 31 | | | 2025 | | 2024 | | | In millions | | Deferred tax assets | $ | 3,318 | | | $ | 3,311 | | | Deferred tax liabilities | (16) | | | (31) | | | Total | $ | 3,302 | | | $ | 3,280 | |
|
| Schedule of Deferred Tax Assets for Net Operating Loss Carryforwards |
As of October 31, 2025, HP had recorded deferred tax assets for net operating loss (“NOL”) carryforwards as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Gross NOLs | | Deferred Taxes on NOLs | | Valuation allowance | | Initial Year of Expiration | | | In millions | | | | Federal | $ | 33 | | | $ | 7 | | | $ | (1) | | | 2026 | | State | 1,817 | | | 97 | | | (23) | | | 2026 | | Foreign | 24,134 | | | 6,471 | | | (6,027) | | | 2028 | | Balance at end of year | $ | 25,984 | | | $ | 6,575 | | | $ | (6,051) | | | |
|
| Schedule of Deferred Tax Assets for Various Tax Credit Carryforwards |
As of October 31, 2025, HP had recorded deferred tax assets for various tax credit carryforwards as follows: | | | | | | | | | | | | | | | | | | | | Carryforward | | Valuation Allowance | | Initial Year of Expiration | | | In millions | | | | | | | | | | Tax credits in state and foreign jurisdictions | $ | 307 | | | $ | (61) | | | 2026 | | U.S. R&D and other credits | 52 | | | — | | | 2045 | | Balance at end of year | $ | 359 | | | $ | (61) | | | |
|
| Schedule of Deferred Tax Asset Valuation Allowance and Changes |
The deferred tax asset valuation allowance and changes were as follows: | | | | | | | | | | | | | | | | | | | | For the fiscal years ended October 31 | | | 2025 | | 2024 | | 2023 | | | In millions | | Balance at beginning of year | $ | 6,688 | | | $ | 6,994 | | | $ | 7,592 | | | Income tax (benefit) expense | (230) | | | (300) | | | (650) | | | Goodwill, other comprehensive loss (income), currency translation and charges to other accounts | 21 | | | (6) | | | 52 | | | Balance at end of year | $ | 6,479 | | | $ | 6,688 | | | $ | 6,994 | |
|